AVE 25.0% 0.3¢ avecho biotechnology limited

new ceo and board 'business model', page-41

  1. 3,268 Posts.
    lightbulb Created with Sketch. 86
    Good point turps...who is managing the tretinoin/tpm trials now?

    "The Tretinoin/TPM® clinical program is being overseen by our recently appointed Chief Operating Officer (COO), Sally Kinrade, who is responsible for managing clinical
    programs and all operational activities of the Company."

 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
(20min delay)
Last
0.3¢
Change
0.001(25.0%)
Mkt cap ! $7.923M
Open High Low Value Volume
0.3¢ 0.3¢ 0.3¢ $1.25K 500K

Buyers (Bids)

No. Vol. Price($)
44 41780232 0.2¢
 

Sellers (Offers)

Price($) Vol. No.
0.3¢ 44100695 25
View Market Depth
Last trade - 12.00pm 10/09/2024 (20 minute delay) ?
AVE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.